Key deals this week: EnLink Midstream, Peabody, StoneCo, UniCredit and more
Contributor since / Followers
Bevan Goldswain
Here’s a list of key deals reported this week across sectors:
Oneok (OKE) said Sunday it agreed to acquire all remaining publicly-held units it does not already own of EnLink Midstream (NYSE:ENLC) for $4.3B in common stock.
Grifols (NASDAQ:GRFS) shares fell in European trading on Wednesday after multiple media reports indicated that Canadian asset manager Brookfield Asset Management (NYSE:BAM) has dropped its plans to take the plasma therapeutics company private.
Summit Materials (NYSE:SUM) agreed to be acquired by privately-held Quikrete Holdings for $52.50/share in cash, for a total enterprise value of about $11.5B including debt.
Italian lender UniCredit (OTCPK:UNCRY) has offered to acquire smaller rival Banco BPM (OTCPK:BNCZF) in a surprise all-stock deal valued at around €10.1B ($10.59B), as it seeks to boost its competitive position in Italy.
Peabody (NYSE:BTU) to acquire steelmaking coal assets from Anglo American (OTCQX:AAUKF) in a $3.78 billion deal that accelerates its strategy to reweight its global coal portfolio toward seaborne metallurgical coal.
OpenAI employees will reportedly have the option of cashing out of their shares worth around $1.5B in a tender offer to SoftBank (OTCPK:SFTBY).
Clinical-stage allogeneic cell therapy and genetic medicines company Poseida Therapeutics (NASDAQ:PSTX) to be acquired by Roche Holdings (OTCQX:RHHBF) for a total equity value of ~$1.5B.
Publicis (OTCQX:PUBGY) is said to be looking at a potential takeover of rival advertising agency Interpublic Group (NYSE:IPG).
Brazilian fintech firm StoneCo (NASDAQ:STNE) has received multiple offers for its software unit Linx, though the bids are below what it paid for the business in 2020.
Aviva submitted a non-binding offer for Direct Line (OTCPK:DIISF) for £3.3B, or about 250 pence per share, according to a statement on Wednesday.
Lifeway Foods (NASDAQ:LWAY) rose 4% after the maker of Kefir products said it’s not opposed to a sale at any price after it rejected Danone’s (OTCQX:DANOY) $27 a share offer last week.